SE9702681D0 - Method and composition for treatment of impotence - Google Patents

Method and composition for treatment of impotence

Info

Publication number
SE9702681D0
SE9702681D0 SE9702681A SE9702681A SE9702681D0 SE 9702681 D0 SE9702681 D0 SE 9702681D0 SE 9702681 A SE9702681 A SE 9702681A SE 9702681 A SE9702681 A SE 9702681A SE 9702681 D0 SE9702681 D0 SE 9702681D0
Authority
SE
Sweden
Prior art keywords
impotence
treatment
composition
compositions
transurethral
Prior art date
Application number
SE9702681A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9702681A priority Critical patent/SE9702681D0/sv
Publication of SE9702681D0 publication Critical patent/SE9702681D0/sv
Priority to JP2000501755A priority patent/JP2001509485A/ja
Priority to DE69819515T priority patent/DE69819515T2/de
Priority to US09/462,450 priority patent/US6476074B1/en
Priority to PCT/SE1998/001367 priority patent/WO1999002164A1/en
Priority to AU83682/98A priority patent/AU752049B2/en
Priority to EP98934081A priority patent/EP1003520B1/en
Priority to CA002295721A priority patent/CA2295721A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9702681A 1997-07-10 1997-07-10 Method and composition for treatment of impotence SE9702681D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence
JP2000501755A JP2001509485A (ja) 1997-07-10 1998-07-10 勃起不全を処置するための方法および組成物
DE69819515T DE69819515T2 (de) 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
US09/462,450 US6476074B1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
PCT/SE1998/001367 WO1999002164A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
AU83682/98A AU752049B2 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
EP98934081A EP1003520B1 (en) 1997-07-10 1998-07-10 Hydroxy-prostaglandin derivatives for the treatment of erectile dysfunction
CA002295721A CA2295721A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence

Publications (1)

Publication Number Publication Date
SE9702681D0 true SE9702681D0 (sv) 1997-07-10

Family

ID=20407719

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence

Country Status (8)

Country Link
US (1) US6476074B1 (sv)
EP (1) EP1003520B1 (sv)
JP (1) JP2001509485A (sv)
AU (1) AU752049B2 (sv)
CA (1) CA2295721A1 (sv)
DE (1) DE69819515T2 (sv)
SE (1) SE9702681D0 (sv)
WO (1) WO1999002164A1 (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
WO2000051978A1 (en) 1999-03-01 2000-09-08 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
AU7557600A (en) 1999-10-07 2001-05-10 Ono Pharmaceutical Co. Ltd. Erection insufficiency remedies
IL139941A0 (en) * 1999-12-02 2002-02-10 Pfizer Prod Inc Use of prostaglandin agonists to treat erectile dysfunction or impotence
DK1132086T3 (da) 2000-01-31 2006-08-28 Pfizer Prod Inc Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
CA2416709A1 (en) * 2000-07-31 2003-01-17 Ono Pharmaceutical Co., Ltd. Therapeutic agent for erectile dysfunction containing as the active ingredient prostaglandin derivatives
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
ATE366571T1 (de) * 2001-07-16 2007-08-15 Hoffmann La Roche 2 pyrrolidon-derivate als prostanoid-agonisten
MXPA04000757A (es) 2001-07-23 2004-07-08 Ono Pharmaceutical Co Remedios para enfermedades con perdida de masa de hueso que tienen agonistas ep4 como ingrediente activo.
AU2003233729B2 (en) * 2002-06-06 2007-10-04 Merck Frosst Canada Ltd 1,5-distributed pyrrolid-2-one derivatives for use as EP4 receptor agonists in the treatment of eye diseases such as glaucoma
AU2003272963A1 (en) 2002-10-10 2004-05-04 Ono Pharmaceutical Co., Ltd. Endogenous repair factor production promoters
CA2513652A1 (en) 2003-03-03 2004-09-16 Applied Research Systems Ars Holding N.V. G-lactam derivatives as prostaglandin agonists
US7465755B2 (en) 2003-07-18 2008-12-16 Laboratoires Serono Sa Hydrazide derivatives as prostaglandin receptors modulators
ATE455760T1 (de) 2004-12-06 2010-02-15 Merck Serono Sa Pyrrolidin-2-on-derivate zur verwendung als dp1- rezeptoragonisten
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
AU2007233212B2 (en) * 2006-04-04 2012-09-13 Allergan, Inc. Therapeutic prostaglandin compounds for the treatment of glaucoma
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
ES2733998T3 (es) 2012-10-29 2019-12-03 Cardio Incorporated Agente terapéutico específico de enfermedad pulmonar
US9968716B2 (en) 2013-10-15 2018-05-15 Ono Pharmaceutical Co., Ltd. Drug-eluting stent graft
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190670A (en) * 1974-03-26 1980-02-26 Gist Brocades N.V. Prostaglandin derivatives
WO1993000894A1 (en) 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction

Also Published As

Publication number Publication date
AU752049B2 (en) 2002-09-05
EP1003520A1 (en) 2000-05-31
DE69819515T2 (de) 2004-09-23
CA2295721A1 (en) 1999-01-21
EP1003520B1 (en) 2003-11-05
WO1999002164A1 (en) 1999-01-21
DE69819515D1 (de) 2003-12-11
AU8368298A (en) 1999-02-08
JP2001509485A (ja) 2001-07-24
US6476074B1 (en) 2002-11-05

Similar Documents

Publication Publication Date Title
SE9702681D0 (sv) Method and composition for treatment of impotence
IL141120A0 (en) Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
EA200300387A1 (ru) Ингибиторы рецептора ep4 для лечения ревматоидного артрита
PT957914E (pt) Formulacao de agonistas de 5-ht
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
FR12C0052I2 (fr) Utilisation de dapoxetine, un inhibiteur selectif de recaptage de serotonine a action rapide, pour traiter un dysfonctionnement sexuel
NO20001744L (no) FremgangsmÕter for Õ behandle psykose forbundet med glykokortikoidrelatert dysfunksjon
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
NZ511131A (en) Estrogen agonists/antagonists and cGMP elevators for treating female sexual dysfunction
NO982264L (no) Inhibitor av cyklofilinrotamaseaktivitet
CO5050298A1 (es) Metodo y composicion para tratar impotencia
FI954944A0 (sv) Indolderivat som 5-HT1-liknande agonister användning vid behandling av migrän
ATE455560T1 (de) Topische zusammensetzungen enthaltend einen alpha 1-adrenergic blocker zur behandlung von schmerzhaften zuständen der analregion
HK1029520A1 (en) Method for preventing hiv-1 infection of cd4+ cells
DE60113290D1 (de) Behandlung von sexueller funktionsstörung mit bombesin rezeptor antagonisten
DE60011748D1 (de) Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
ES2178851T3 (es) Procedimiento para el tratamiento de un articulo que contienen un compuesto organico oxidable.
EP1108426A3 (en) Use of prostaglandin agonists to treat erectile dysfunction or impotence
BR9809848A (pt) Composição
MXPA03004547A (es) Agonistas receptores de d4 de dopamina selectivos para el tratamiento de disfuncion sexual.
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba